An analysis of a series of five peptides composed of various portions of the pleurocidin (Plc) sequence identified a l2-amino acid fragment from the C-terminus of Plc, designated Plc-2, as the smallest fragment that retained a antimicrobial activity comparable to that of the parent compound. MIC tests in vitro with low-ionic-strength medium showed that Plc-2 has potent activity against Pseudomonas aeruginosa, Escherichia coli and Staphylococcus aureus but not against Enterococcus faecalis. The antifungal activity of the synthetic peptides against phytopathogenic fungi, such as Fusarium oxysporum, Colletotrichum sp., Aspergillus niger and Alternaria sp., also identified Plc-2 as a biologically active peptide. Microscopy studies of fluorescently stained fungi treated with Plc-2 demonstrated that cytoplasmic and nuclear membranes were compromised in all strains of phytopathogenic fungi tested. Together, these results identify Plc-2 as a potential antimicrobial agent with similar properties to its parent compound, pleurocidin. In addition, it demonstrated that the KHVGKAALTHYL residues are critical for the antimicrobial activity described for pleurocidin.
Introduction
Eukaryotic antimicrobial peptides (AMPs) are a promising class of molecular tools that have tremendous potential to be clinically relevant due to their activity against a wide spectrum of microorganisms. Over the last few decades, intense research has been focused on their biosynthesis and the mechanisms of their activity [6, 16] . They are important components of the natural defenses of most living organisms and have been isolated from a wide variety of animals, plants and bacteria (http://www.bbem.univ.triest.it/-tossi/search.htm). Many of these AMPs are genetically encoded, while others are secondary metabolites. Yet, both avenues generate peptides that display positive, negative or neutral net charge in physiological pH.
The positive charge of the vast majority of AMPs allows the initial interaction with the negatively charged lipopolysacharides (LPS) in the outer membrane, and later, with negatively charged phospholipids in the inner membrane. However, there are exceptions such as the magainins and cecropins, which do not show any interaction with chiral centers in the membrane since the L and D enantiomers of these peptides have similar antimicrobial activity. In contrast, apidaecin kills bacteria by a mechanism that involves stereospecificity. The selectivity of these peptides for bacterial membranes over eukaryotic membranes has been ascribed to the lack of cholesterol and cationic lipids in the bacterial membranes and the limited amounts of anionic lipids in the eukaryotic membranes.
The skin and skin mucus of several fish species have been shown to contain AMPs. A number of those show sequence similarity to AMPs isolated from other organisms. Pleurocidin (Plc), a ␣-helical cationic peptide isolated from the skin-secreted mucous of the winter flounder Pleuronectes americanus [6, 7] is predicted as a 60 or 68 residue precursor prepropolypeptide that undergoes proteolytic a The molecular moment (Mm) was calculated by the method of Eisenberg et al. [11] , as described in Section 2. Plc, pleurocidin peptide.
cleavage of its amino-terminal signal and carboxy-terminal anionic propiece to form the active peptide [8, 9] . The resulting active peptide consists of 25 amino acid residues and possesses a net positive charge at physiological pH. The activity has been extensively explored and has shown a broad spectrum of antimicrobial and hemolytic activity [14, 17, 40, 42] . Its codifying gene is similar to the structural gene of the mammalian antimicrobial peptide PR-39 [15] and its primary structure showed some homology with the dermaseptins from frogs [28] and ceratotoxins (medflies) [24] classes of AMPs [31, 33] . The presence of common motifs in PR-39, dermaseptins and ceratotoxins, suggests that the antimicrobial activity of pleurocidin is due to only a portion of the pleurocidin sequence. Furthermore, to make Plc useful as a therapeutic drug requires delineating the feature responsible for its activities as an AMP.
There are examples of peptide and protein fragments retaining the antimicrobial activity of the parent molecule and, in some instance, their activities even exceed that of a close relative molecule [5, 21] . In addition, the N-and C-terminal regions of antimicrobial peptides play an important role in the organism-specific interaction process or pore formation in plasma membrane [4, 23] . AMPs are not only an interest against human pathogens, they are also excellent candidates for serving as biologically based pesticides for agriculture. To capitalize on their potential use, studies are in progress to elucidate the mechanisms of their action with an ongoing search to identify the particular residues and structural elements responsible. Such endeavors can lead to modifications towards more selective compounds with lower intrinsic toxicity and reduced negative environmental impacts [27] . Towards this goal, an analysis of the peptide fragments in pleurocidin was initiated. In this study, the activity of the peptides was examined against bacteria and filamentous phytopathogenic fungi. We discovered that a small sequence of the 12 amino acid C-terminus (KHVGKAALTHYL) possed a high percentage (≥80%) of the precursor's lytic activity against Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli and no effect or very small effect against Enterococcus faecalis. In fungi of agronomical interest, a high activity was observed against all the fungi evaluated, except Aspergillus ochraceus. The measured MIC values were close to those of commercial fungicides. Four other synthetic peptides, spanning the whole pleurocidin sequence, were tested, but a reduced growth inhibition was obtained for P. aeruginosa and for the three other bacteria species compared to pleurocidin.
Materials and methods

Materials
Amino acids for peptide synthesis were acquired from Calbiochem-Novabiochem Corp. (Germany). The sequencing reagents and HPLC columns were from Shimadzu (Kyoto, Japan). Piperidine, acetonitrile and trifluoroacetic acid were purchased from Fluke. Brain heart infusion broth (BHI), trifluoroethanol and all other analytical reagents were purchased from Merck (Darmstad, Germany). Sytox green (SG) was acquired from Molecular Probes (Invitrogen Corp, Carlsbad, CA, USA) and calcofluor white (CFW) (Fluorescent Brightener 28) from Sigma-Aldrich (St Louis, MO, USA). Potato dextrose broth (PDB) and potato dextrose agar (PDA) were purchased from HiMedia (Mumbai, India) and Oxoid (Hampshire, England), respectively.
Microorganisms
The following bacteria were used for testing the AMP activity of the pleurocidin fragments; wild-type bacteria E. faecalis (ATCC-29212), E. coli (ATCC-35218), P. aeruginosa (ATCC-27853) and S. aureus (ATCC 25325). All bacteria were obtained from the National Institute of Health Quality Control (INCQS), Oswaldo Cruz Foundation, RJ, Brazil and maintained in tubes with BHI at 37 • C until reaching the exponential log phase. All strains were stored at −80 • C until use and cultures were grown in 3% (w/v) Trypticase Soy Broth (TBS) at 37 • C.
Six fungal isolates, all known plant pathogens, were used for antifungal activity assays. The fungi Alternaria sp., Fusarium oxysporum, A. niger, A. ochraceus, Cladosporium fulvum and Colletotrichum sp. were supplied by the Department of Protección Vegetal of the Instituto Nacional de Investigación Agropecuaria (INIA, Las Brujas, Uruguay). Fungi were cultured on PDA at 27 • C. Fungal spores were collected as described [2] . The concentration of the sporangial suspensions were estimated using a cell counting chamber and adjusted to 2 × 10 6 spores mL −1 [1] , and stored in 20% glycerol at −80 • C until use.
Peptide synthesis
Peptides were synthesized by the solid-phase synthesis method in a PSS-8 (Shimadzu, Kyoto, Japan) Pep Synthesizer according to the fluoren-9-methyloxycarbonyl (Fmoc)-polyamide active ester chemistry [26] . The synthesized peptides were purified using a Vydac (Altech Associates, Inc., USA) reverse-phase C18 column and the purity was confirmed by matrix-associated laser desorption ionization (MALDI) mass spectroscopy (Kratos Kompact MALDI, Manchester, UK). The amino acid sequences of the peptides are listed in Table 1 .
Before the biological assays, lyophilized peptides were solubilized in sterile Milli-Q water to a final concentration of 1 mM and filtered sterilized through a 0.22-m pore filter.
Computational analysis and molecular moment calculation
The mean hydrophobic moment ( H) values for the pleurocidin peptide fragments at different angles (ı) were calculated as described [10, 11] by the equation:
where N is the number of residues and n is the specific residue within the peptide sequence; H n is the hydrophobic value, according to the normalized consensus hydropathy scale [34] assigned to residue n; and ␦ is the angle (in radians) between successive residues (e.g., ı is equal to 100 • for an ␣ helix).
Assay of bactericidal activity
Screening for the bacterial effect was performed at a peptide concentration of 100 g mL −1 using the tube dilution method. Briefly, 0.9 mL of the bacterial suspension was incubated with 0.1 mL of peptide solution (1 mg mL −1 ) at 37 • C for 2 h, aerobically. Growth controls were performed with brain heart infusion (BHI) and saline. Negative growth controls were performed under the same conditions with 10 g mL −1 of gentamicin. Colony formations units (CFU) were counted by streaking remaining bacteria on Mueller-Hinton Agar.
Antimicrobial colony forming unit (CFU) assay and determination of MIC
First, 5 × 10 5 CFU mL −1 was incubated for 18 h at 37 • C in a final volume of 100 l of MHB with 0.1-100 g mL −1 of peptides using 24-well polypropylene plates. Visual verification of microbial sedimentation and the absorbance at 600 nm confirmed the minimal inhibitory concentration (MIC). The minimal bactericidal concentration (MBC) was determined by streaking 5-L aliquots of the microtiter plate reaction mixtures used to determine the MIC onto a Mueller-Hinton (MHB) agar plate. The wells containing the three serial dilutions above and below the MIC were analyzed. The lowest concentration of peptide that ablated the bacterial colony growth on the agar plate was deemed the MBC.
Assay of antifungal activity
The in vitro antifungal activities of peptide solutions were determined by a quantitative micro-spectrophotometric assay [2] . Inhibition of growth was measured in 96-well microtiter plates at 595 nm. Routine tests were performed with 20 L of a peptide test solution, 10 L of a spore suspension (2 × 10 6 spores mL −1 ) and 70 L of potato dextrose broth (PDB) (HiMedia, Mumbai, India). Microcultures containing 20 L of sterile distilled water in place of test solutions were used as negative control. The commercial fungicide Captan (0.2 mg mL −1 ) [35] was used as the positive control. The plates were allowed to stand for 30 min at 27 • C to allow the spores to sediment, after which, the absorbance was measured at 595 nm in a Multiscan Spectrum microplate reader (Thermo Electron Corp., Varta, Finland). After a 48 h incubation at 27 • C, growth was recorded by measuring absorbance. All assays for antifungal activity were performed, at a minimum, in triplicate. The growth inhibition percentage was determined based on the equation [( C − T)/ C] × 100, where C was the corrected absorbance of the control microculture at 595 nm and T was the corrected absorbance of the test microculture. The corrected absorbance values equaled the absorbance at 595 nm of the culture measured after 48 h minus the absorbance at 595 nm measured after 30 min.
Determination of the fungal MIC and MFC
A microplate method, as previously described [13] , was used with slight modifications to determine the MIC of peptide test solutions. Briefly, 20 L from a 500 g mL −1 stock solution was added to the first column of a microplate. Then, double serial dilutions were performed using distilled sterile water for the remaining columns. In each well, 20 L of peptide dilutions were mixed with 180 L of the fungal spore suspension (2 × 10 6 spores mL −1 in fresh PDB). The microplates were incubated for 48 h at 27 • C. All experiments were performed in triplicate. The MIC readings were measured as absorbance at 595 nm. MIC was defined as the lowest peptide concentration that inhibited 90% fungal growth. The in vitro minimal fungicidal concentration (MFC) was determined as described by Espinel-Ingroff et al. [12] . After a 48 h incubation, 20 L from each well was subcultured onto PDA and incubated at 27 • C until growth was observed in the growth control subculture. Cultures with the lowest peptide concentration that displayed no visible growth (representing an inhibition >98%) in comparison to cultures from the positive well (Captan) and the growth control well (peptide-free medium) onto PDA plates were used to determine the MFC.
Microscopic visualization
The mycelium of the different test fungi was grown for 48 h (2 × 10 6 spores mL −1 in PDB) before culturing in the presence of peptides at different concentrations. After 48 h, specimens were stained with two different fluorescent dyes [32] . First, the SG stock solution (4 mol L −1 ) was added to a final concentration of 0.2 mol L −1 . After 5 min in the dark, 0.1% (w/v) CFW was added to a final concentration of 50 g mL −1 and samples were incubated again for 5 min in the dark [29] . Finally, the mycelium was washed with sterile water, centrifuged and resuspended in 20% glycerol. Wash conditions were determined based on evaluations of the mycelium structure. Fluorescence signals were imaged using a fluorescence microscope with the corresponding filters (Optiphot-2, Nikon, Japan).
Hemolytic activity
Peptides were screened for hemolytic activity by treating a 1% suspension of freshly isolated and washed human red blood cells (O + donor) in PBS, pH 7.4. Peptide samples (10 L) at various concentrations (5-100 g mL −1 ) were added and, after gentle mixing, the tubes were incubated at 37 • C for 30 min before centrifugation (4000 × g for 5 min at 25 • C). Supernatants (100 l) were removed and diluted ten fold with PBS. The absorbance at 567 nm was measured and the relative optical density was compared to that of a cell suspension treated with 0.2% Triton X-100 (100% hemolysis).
Results
3.1.
Peptide design and identification of Plc-2 as the core pleurocidin fragment retaining full antibacterial activity Antimicrobial activities of derived pleurocidin peptides were evaluated using Gram-positive (S. aureus and E. faecalis) and Gram negative (P. aeruginosa and E. coli) representative bacteria. Detection and quantification of antimicrobial activity were determined by reduction of Alamar Blue. An evaluation of the Plc-2 fragment began by testing the synthetic peptides Plc-1-5, which represent the N-terminal, middle, and C-terminal segments of pleurocidin (Table 1 ). Significant killing activity against E. coli, S. aureus and P. aeruginosa was retained only by Plc-2 and the Plc-4 as compared to the parent peptide of pleurocidin. The MIC ranged from 4.0 M to Table 2) . The relationship between bacterial growths inhibitions versus peptide dose is shown in Fig. 1 . Plc-2 and Plc-4 inhibited growth of S. aureus and E. coli at 2.5 ( Fig. 1) and 5 g/ml (data not shown) peptide concentrations, respectively. Plc-1, Plc-3, Plc-4 and Plc-5 did not exhibit any growth inhibition. Plc-3 and Plc-5 also failed to show any antimicrobial activities through all the tested concentrations. Notably, Plc-2 showed the highest antimicrobial activity in the experiment with S. aureus, and E. coli and it functioned at a 2.5 g mL −1 peptide concentration. Plc-2 and Plc-4 have the sequence KHVGKAAL in common. The antimicrobial activity of Plc-2 was comparable to the original pleurocidin peptide, which indicated that the C-terminal duodecapeptide was the minimal active fragment and that the C-terminal Tre, His, Tyr, Lys residues of Plc were required together for activity.
Antifungal activity
Antimicrobial peptides target cytoplasmic membranes and intracellular macromolecules. As a general feature, most antimicrobial peptides are amphipathic and this property serves a key role in their antimicrobial activity by promoting microbial membrane interactions. However, microbial cell surfaces such as membranes or cell walls are composed of a variety of components, which generate significant differences between the surfaces of prokaryote and eukaryote cells [17, 18, 42, 44] . Previous studies have shown that the pleurocidin peptide presents a selective membrane-disruption effect in some fungi [22] , but its mechanism of action remains to be determined.
The antifungal activities of the short pleurocidin peptides were screened in vitro against Alternaria sp. and F. oxysporum. Table 3 shows the MIC and MFC values for the different fungi. The MIC and MFC values of pleurocidin ranged from 0.79 g mL −1 to >25 g mL −1 and 3.12 g mL −1 to >50 g mL −1 , respectively. Whereas the MIC and MFC values of Plc-2 ranged from 3.12 g mL −1 to >50 g mL −1 and 6.25 g mL −1 to >50 g mL −1 , respectively. These values illustrate the relative antifungal potency of the two peptides, with MIC values quite comparable to the conventional fungicide captan. The highest inhibitory activity of the two peptides was observed against Colletotrichum sp., and the lowest inhibition was noted against A. ochraceus. Plc-2 was less active than pleurocidin, except against F. oxysporum, for which the MIC and the MFC values were the same. Both peptides exhibited fungistatic and fungicidal activity for all the ascomycete fungi tested.
Morphological alterations
Significant morphological changes were observed when the phytopathogenic fungi were exposed to pleurocidin and Plc-2 at concentrations that partially inhibit growth (Fig. 2) . Most of these fungi exhibited increased branching (hyper-branching) and swelling of the hyphae in the presence of the peptides. Condensed hyphal aggregates were commonly observed when fungi were treated with peptides followed by staining with CFW. The fluorescent probe SG was used to assess cell permeation of fungi treated with both peptides. All the fungi showed identical fluorescent staining. Cellular membranes were compromised and also disrupted if the fungal structures were incubated with pleurocidin or Plc-2 (Fig. 2) .
Structural and compositional studies of Plc-2
The fact that Plc-2 is reduced in size compared to pleurocidin might alter its structural properties. The Plc-2 peptide presented the smallest charge (+2) and highest pI (9.7). Its major molecular moment (0.16) was at the low end for all of the synthesized peptides (Table 1) . Comparing the primary structure of Plc-2 with the structure of antimicrobial peptides with similar activity (dermaseptin-1, ceratotoxin and PR39) together with the results presented here ( Fig. 1 and Table 2 ), it can be determined that the sequence GKAAL was the critical amino acid sequence for the antimicrobial activity associated with the parental pleurocidin antimicrobial peptide.
The Schiffer-Edmundson helical wheel showed that the amphipathic ␣-helical structure (containing hydrophobic residues on one face of the helix and hydrophilic residues on the opposite face) present in the pleurocidin is also present in the Plc-2 (Fig. 3) .
Discussion
Pleurocidin is one of the most noteworthy antimicrobial peptides studied in the past few years. It displays a broad spectrum of activity against bacteria, fungus and some leukemical and eukaryotic cells [17] . In general, the activity of AMP depends on the composition of the membranes with which it interacts together with its structural features; primary structure, conformation, net charge, net hydrophobicity, hydrophobic moment, amphipathicity, size, and polar angle [43] .
Therefore, to find the minimal active fragment, Plc was further truncated and assayed against a representative set of Gram-positive (S. aureus and E. faecalis) and Gram negative (P. aeruginosa and E. coli) bacteria and fungi. The bacterium S. aureus has acquired a number of genes that provide antibiotic resistance against all penicillins, including methicillin and other narrow-spectrum ␤-lactamase-resistant penicillin antibiotics. Recently, it has become the major cause of hospital-acquired infections [33] . The strain P. aeruginosa typically infects the pulmonary tract, urinary tract, burns, and wounds and also causes other blood infections. It has been reported to be responsible for one in ten hospital-acquired infections are from Pseudomonas [30, 39] .
An important distinction for Gram-positive bacteria is that they possess thicker cell wall than Gram-negative organisms. This peptidoglycan layer of Gram-positive bacteria remains a relatively porous structure [38] . The essential function of the cell wall is to serve as a selective permeability barrier, protecting bacteria from harmful agents, such as detergents, drugstoxins and degradative enzymes, yet allow the penetration of nutrients to sustain bacterial growth. Evidence from genetic and chemical experiments have proven that the cell wall plays an essential role in providing a selective permeability barrier for S. aureus and other Gram-positive bacteria. The peptide fragments used here caused cell wall effects such as breaks, thinning, and disintegration as well as abnormal septation. Our experimental results using Plc-1-5, which represent the N-terminal, middle, and C-terminal segments of pleurocidin suggested that only the amino acids present in Plc-2 enhanced the permeability of membrane with a similar potency of the parent molecule, which requires passage through the cell wall.
Examining the data in Table 1 , the hydrophobicity of the peptides was determined not to be a possible element of influence on the observed activities. Therefore, it was assumed that the structure would be a primary contributing aspect to the mechanism of action. The C-terminal Plc-2 fragment (KHVGKAALTHYL) of pleurocidin showed a perfect amphipathic structure in a ␣-helical wheel diagram (Fig. 3) . Most AMPs are an amphipathic and this property is a key role in antimicrobial activity by microbial membrane interaction. In fact, it was previously demonstrated that the pleurocidin had a ␣-helical structure in the membrane-mimetic condition [36] . Similarly, NMR structural studies that covered all of the Plc-2 peptide sequence showed that in an aqueous solution the Plc presents a random coil conformation [37] . However, it assumed an ␣-helical structure in TFE and in dodecylphosphocholine (DPC) micelles [22] . Thus, the Plc-2 ␣-helical structure described in this work is similar to that for many other AMPs, which cause lysis and release of intracellular contents by binding to the surface of bacterial membranes. The ␣-helical structure produces a significant destabilizing effect upon membranes, which insert themselves into the membrane by binding more efficiently than other structural configurations [19] . This conclusion is also in agreement with a report from Yamada and Natori [41] , in which the fragment corresponding to the ␣-helical region of sapecin B, a derived peptide belonging to the insect defensin family, showed broad antibacterial activity.
However, antimicrobial activity is not restricted exclusively to ␣-helical structures. Lee et al. [27] attributed the activity of the AMP tenecin to a fragment (amino acids 29-43) located in a ␤-sheet region of the peptide. Similarly other authors founded that the antimicrobial activity of some peptides was establish in amphipathic beta-sheet segments [19] . Microbial cell surfaces such as membranes or cell wall are composed of various components, and they exhibited significant differences in surface components between bacteria and fungi. Therefore, it may be possible the membrane composition influences the activity of an AMP by influencing preferential interactions with ␣-helical or ␤-sheet structures.
Some known AMP can induce abnormal morphological changes in the hyphae structure of phytopathogenic fungi [3] and human pathogenic fungi [20] . In our study, we chose to examine two fungi examined Alternaria sp. and F. oxysporum that are of economical importance. The abnormal morphological changes in membrane structure of hyphae were evaluated in vivo with the fluorescent membrane probe SG. This probe was used to assess cell permeation of fungi treated with both peptides. All the fungi showed identical fluorescent staining. Cellular membranes were compromised and also disrupted if the fungal structures were incubated with pleurocidin or Plc-2. The MIC and MFC values measured illustrate the relative antifungal potency of the two peptides with MIC values quite comparable to the conventional fungicide captan.
The highest inhibitory activity of the two peptides was observed against Colletotrichum sp., and the lowest inhibition was noted against A. ochraceus (Table 2 ). Plc-2 was less active than pleurocidin, except against F. oxysporum, for which the MIC and the MFC values were the same. From these studies, we conclude that both peptides exhibited fungistatic and fungicidal activity for all the ascomycete fungi tested. In order to understand the correlation between antifungal activity and cell-surface accumulation, we examined the effects of the peptides on the cell. The integrity of the cell wall, cellular membrane and the nuclear membrane were compromised since nuclear staining was used as an indicator for the degree of access from membrane damage by antifungal activity. These results indicate that the antifungal effects of Plc-2 are due to the accumulation of Plc-2 within the plasma membrane through interaction between peptides and the plasma membrane, rather than with the cell wall. Therefore, membrane damage from the membrane interaction of Plc-2, is the major cause of cell death. The results are also supported by amphipathic ␣-helical conformation as the structural feature of Plc-2, which is presented by Schiffer-Edmundson helical wheel modeling. Amphipathic ␣-helical peptides, with antibacterial activity, exhibit membrane-disrupting activity and Plc also displays ␣-helical structure in an aqueous solution, as well as in membrane mimetic environments [25] . Comparing the primary structure of Plc-2 with the structure of other antimicrobial peptides with similar activity (dermaseptin-1, ceratotoxin and PR39) and the results obtained in this work ( Fig. 1 and Table 2 ) it can be strongly suggested that the sequence GKAAL was the critical amino acid sequence for the antimicrobial activity of the pleurocidin antimicrobial peptide.
In summary, the potential of Plc-2 as a therapeutic peptide agent was investigated and the results suggested that one possible reason for it exerting a similar activity of Plc was because it appeared to maintenance of the native structure of pleurocidin. Actually, Plc-2 itself had strong antimicrobial activity with a much lower hemolytic effect in comparison with melittin and other well known antibiotics, such as ampicillin, vancomycin, cefotaxime, chloramphenicol and kanamycin (data not shown). Thus, when the problem of the structure of Plc-2 is improved by peptide engineering, this peptide may help form a leading model for developing new and novel therapeutic agents.
Conclusions
In this study, we investigated the antibacterial and antifungal activities to determine mechanisms of action for pleurocidin and short Plc derived peptides. Our results from anti-bacterial activity indicated that Plc-2 a C-terminal 12-amino acid fragment of pleurocidin contained the critical amino acid for the cytolytic activity. The data also showed that the strong antibacterial activity against human pathogenic Gram-positive and Gram-negative bacteria was not damaging to human erythrocytes. In addition, Plc-2 also exhibits a potent activity against fungicide-resistant pathogens. Staining experiments indicated that both pleurocidin and Plc-2 compromised the integrity of the fungi membrane and, in addition bind to nuclear acid, thus affecting the nuclear membrane. The antifungal effects of Plc-2 are thought to be due to membrane disruption after the accumulation in the plasma membrane of the fungal cell. Thus, the broad activity of this peptide may be helpful to form a leading model for developing new and novel therapeutic agents for public health and could have applications to commercial agriculture.
